In a cohort study from Japan, the risk of metabolic syndrome and diabetes increased with the levels of hepatic enzymes, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), and GGT, among the metabolic syndrome–free participants [16]. The gene discussed is GPT; the disease is metabolic syndrome.